Literature DB >> 20305083

Solitary confinement and mental illness in U.S. prisons: a challenge for medical ethics.

Jeffrey L Metzner1, Jamie Fellner.   

Abstract

In recent years, prison officials have increasingly turned to solitary confinement as a way to manage difficult or dangerous prisoners. Many of the prisoners subjected to isolation, which can extend for years, have serious mental illness, and the conditions of solitary confinement can exacerbate their symptoms or provoke recurrence. Prison rules for isolated prisoners, however, greatly restrict the nature and quantity of mental health services that they can receive. In this article, we describe the use of isolation (called segregation by prison officials) to confine prisoners with serious mental illness, the psychological consequences of such confinement, and the response of U.S. courts and human rights experts. We then address the challenges and human rights responsibilities of physicians confronting this prison practice. We conclude by urging professional organizations to adopt formal positions against the prolonged isolation of prisoners with serious mental illness.

Entities:  

Mesh:

Year:  2010        PMID: 20305083

Source DB:  PubMed          Journal:  J Am Acad Psychiatry Law        ISSN: 1093-6793


  12 in total

1.  Public Health and Solitary Confinement in the United States.

Authors:  David H Cloud; Ernest Drucker; Angela Browne; Jim Parsons
Journal:  Am J Public Health       Date:  2015-01       Impact factor: 9.308

2.  Effectiveness of a self-administered intervention for criminal thinking: Taking a Chance on Change.

Authors:  Johanna B Folk; David J Disabato; Jordan M Daylor; June P Tangney; Sharen Barboza; John S Wilson; Lynda Bonieskie; James Holwager
Journal:  Psychol Serv       Date:  2016-05-30

3.  Solitary confinement and risk of self-harm among jail inmates.

Authors:  Fatos Kaba; Andrea Lewis; Sarah Glowa-Kollisch; James Hadler; David Lee; Howard Alper; Daniel Selling; Ross MacDonald; Angela Solimo; Amanda Parsons; Homer Venters
Journal:  Am J Public Health       Date:  2014-03       Impact factor: 9.308

4.  Psychotic-spectrum symptoms, cumulative adversity exposure and substance use among high-risk girls.

Authors:  Amy E Lansing; Wendy Y Plante; Christine Fennema-Notestine; Shahrokh Golshan; Audrey N Beck
Journal:  Early Interv Psychiatry       Date:  2017-12-28       Impact factor: 2.732

5.  Jails as Public Health Partners: Incarceration and Disparities Among Medically Underserved Men.

Authors:  Dora M Dumont; Annie Gjelsvik; Nicole Redmond; Josiah D Rich
Journal:  Int J Mens Health       Date:  2013

6.  Incarceration Rates and Traits of Sexual Minorities in the United States: National Inmate Survey, 2011-2012.

Authors:  Ilan H Meyer; Andrew R Flores; Lara Stemple; Adam P Romero; Bianca D M Wilson; Jody L Herman
Journal:  Am J Public Health       Date:  2016-12-20       Impact factor: 9.308

Review 7.  Rights versus Risks: The Impact of Isolation on Residents and Families in Long-Term Care.

Authors:  Andrea Baumann; Mary Crea-Arsenio
Journal:  Healthc Policy       Date:  2022-06

Review 8.  Ethics, the law, and prisoners: protecting society, changing human behavior, and protecting human rights.

Authors:  Robert L Trestman
Journal:  J Bioeth Inq       Date:  2014-07-05       Impact factor: 1.352

9.  From Punishment to Treatment: The "Clinical Alternative to Punitive Segregation" (CAPS) Program in New York City Jails.

Authors:  Sarah Glowa-Kollisch; Fatos Kaba; Anthony Waters; Y Jude Leung; Elizabeth Ford; Homer Venters
Journal:  Int J Environ Res Public Health       Date:  2016-02-02       Impact factor: 3.390

10.  Identification and treatment of offenders with attention-deficit/hyperactivity disorder in the prison population: a practical approach based upon expert consensus.

Authors:  Susan Young; Gisli Gudjonsson; Prathiba Chitsabesan; Bill Colley; Emad Farrag; Andrew Forrester; Jack Hollingdale; Keira Kim; Alexandra Lewis; Sarah Maginn; Peter Mason; Sarah Ryan; Jade Smith; Emma Woodhouse; Philip Asherson
Journal:  BMC Psychiatry       Date:  2018-09-04       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.